SHELBY SABLJIC: Open Payments
NPI 1568055614 · SUN CITY, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,314 in 44 payments from 14 companies in 2025. Trend: 2023 $688 · 2024 $548 · 2025 $1,314
Food & beverage: $1,314
| Company | Payments | Amount |
|---|---|---|
| AKEBIA THERAPEUTICS INC | 6 | $228 |
| Amgen Inc. | 8 | $193 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $170 |
| Vantive US Healthcare LLC | 2 | $153 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $113 |
| Travere Therapeutics, Inc. | 3 | $90 |
| Calliditas Therapeutics US Inc. | 3 | $70 |
| Ardelyx, Inc. | 3 | $68 |
| Otsuka America Pharmaceutical, Inc. | 3 | $64 |
| AstraZeneca Pharmaceuticals LP | 3 | $61 |
Products named: Vafseo, KRYSTEXXA, Kerendia, JARDIANCE, TARPEYO, IBSRELA, Fabhalta, JYNARQUE.
Industry payments across AZ — which companies pay providers there.
